Dr. Tandon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
303 E Chicago Ave
Chicago, IL 60611Phone+1 312-503-8223- Is this information wrong?
Education & Training
- UPMC Medical EducationFellowship, Hematopathology, 2012 - 2014
- McGaw Medical Center of Northwestern UniversityResidency, Pathology-Anatomic and Clinical, 2008 - 2012
- University of California (Irvine)Residency, Pathology-Anatomic and Clinical, 2008 - 2008
- Eastern Virginia Medical SchoolClass of 2008
Certifications & Licensure
- NY State Medical License 2016 - 2026
- NJ State Medical License 2018 - 2025
- GA State Medical License 2015 - 2023
- TN State Medical License 2015 - 2022
- KY State Medical License 2015 - 2021
- SC State Medical License 2015 - 2021
- NC State Medical License 2015 - 2020
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Pathology - Molecular Genetic
- American Board of Pathology Hematopathology
- Join now to see all
Publications & Presentations
PubMed
- 11 citationsAssociation of Li-Fraumeni Syndrome With Small Cell Carcinoma of the Ovary, Hypercalcemic Type and Concurrent Pleomorphic Liposarcoma of the CervixBevan Tandon, Ian S. Hagemann, Horacio M. Maluf, John D. Pfeifer, Hussam Al-Kateb> ;International Journal of Gynecological Pathology. 2017 Nov 1
- 21 citationsMutational landscape and response are conserved in peripheral blood of AML and MDS patients during decitabine therapy.Eric J. Duncavage, Geoffrey L. Uy, Allegra A. Petti, Christopher A. Miller, Yi-Shan Lee, Bevan Tandon, Feng Gao, Catrina Fronick, Michelle O'Laughlin, Robert S. Fulton...> ;Blood. 2017 Mar 9
- 569 citationsTP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic SyndromesJohn S. Welch, Allegra A. Petti, Christopher A. Miller, Catrina Fronick, Michelle O'Laughlin, Robert S. Fulton, Richard K. Wilson, Jack Baty, Eric J. Duncavage, Bevan ...> ;The New England Journal of Medicine. 2016 Nov 23
- Join now to see all
Press Mentions
- OPKO Health’s BioReference Laboratories to Participate in the National Cancer Institute NCI-MATCH (Molecular Analysis for Therapy Choice) Phase II Clinical TrialAugust 28th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: